Cargando…
The actions and uses of ophthalmic drugs /
The Actions and Uses of Ophthalmic Drugs, Third Edition discuses the application and discrimination in the use of ophthalmic drugs. The book reviews the general pharmacological principles including drug nomenclature, pharmacological classification, pharmacokinetics, pharmacodynamics, and the use of...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London ; Boston :
Butterworths,
1989.
|
| Edición: | 3rd ed. / |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn645465095 | ||
| 003 | OCoLC | ||
| 005 | 20231117033203.0 | ||
| 006 | m o d | ||
| 007 | cr bn||||||abp | ||
| 007 | cr bn||||||ada | ||
| 008 | 100630s1989 enkaf ob 001 0 eng d | ||
| 040 | |a OCLCE |b eng |e pn |c OCLCE |d OCLCQ |d UIU |d OCLCQ |d OCLCF |d IDEBK |d E7B |d N$T |d YDXCP |d EBLCP |d HEBIS |d OCLCQ |d YDX |d OCLCO |d OCLCA |d AU@ |d STF |d OCLCO |d OCLCA |d OCLCQ |d UKAHL |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO | ||
| 019 | |a 609962655 |a 896795715 |a 974619887 |a 1058040032 |a 1100923405 |a 1153547026 | ||
| 020 | |a 9781483192048 |q (electronic bk.) | ||
| 020 | |a 1483192040 |q (electronic bk.) | ||
| 020 | |z 0407007997 |q (alk. paper) ; |q �30.00) | ||
| 020 | |z 9780407007994 |q (alk. paper) ; |q �30.00) | ||
| 035 | |a (OCoLC)645465095 |z (OCoLC)609962655 |z (OCoLC)896795715 |z (OCoLC)974619887 |z (OCoLC)1058040032 |z (OCoLC)1100923405 |z (OCoLC)1153547026 | ||
| 042 | |a dlr | ||
| 050 | 4 | |a RE994 |b .D38 1989 | |
| 060 | 4 | |a WW 166 |b D257a 1989 | |
| 072 | 7 | |a MED |x 085000 |2 bisacsh | |
| 082 | 0 | 4 | |a 617.7/061 |2 20 |
| 100 | 1 | |a Davies, P. H. O'Connor |q (Patrick Henry O'Connor), |d 1922- | |
| 245 | 1 | 4 | |a The actions and uses of ophthalmic drugs / |c by P.H. O'Connor Davies. |
| 250 | |a 3rd ed. / |b rev. by G.A. Hopkins ; optometric adviser, R.M. Pearson. | ||
| 260 | |a London ; |a Boston : |b Butterworths, |c 1989. | ||
| 300 | |a 1 online resource (ix, 248 pages, 4 unnumbered pages of plates) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index. | ||
| 506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
| 533 | |a Electronic reproduction. |b [Place of publication not identified] : |c HathiTrust Digital Library, |d 2010. |5 MiAaHDL | ||
| 538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
| 583 | 1 | |a digitized |c 2010 |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Front Cover; The Actions and Uses of Ophthalmic Drugs; Copyright Page; Foreword; Preface to the third edition; Preface to the first edition; Table of Contents; Chapter 1. General pharmacological principles; Introduction; Sources of drugs; Drug nomenclature; Pharmacological classification; General pharmacological principles; References; Chapter 2. Ocular autonomic innervation and neurohumoral transmission; Intra-ocular musculature; Parasympathetic innervation of the eye (Colour Plate I); Sympathetic innervation of the eye and orbit (Colour Plate I). | |
| 505 | 8 | |a Sensory innervation of the eye and orbit (Colour Plate I)Neurohumoral transmission in the autonomic nervous system (Figure 2.2); Autonomic drugs; Denervation supersensitivity; References; Chapter 3. Basic microbiology; Bacteria; Chlamydiae; Fungi; Micro-organisms and disease; Microbiology of the eye; Some common ocular pathogens; Antimicrobial agents; Hygiene in practice; References; Further reading; Chapter 4. Introduction to ophthalmic drugs; Dosage forms for ophthalmic use; Drug classification; References; Chapter 5. Cycloplegics; Ideal properties of cycloplegics. | |
| 505 | 8 | |a Advantages of cycloplegic refractionDisadvantages of cycloplegic refraction; Precycloplegic examination; Cycloplegic examination; Choice of cycloplegic; Atropine; Cyclopentolate; Tropicamide (Bistropamide); Other cycloplegics; Adverse effects of cycloplegics; References; Chapter 6. Mydriatics; Ideal properties of mydriatics; Indications; Contra-indications; Mode of action; Antimuscarinic mydriatics; Sympathomimetic mydriatics; Antimuscarinic or sympathomimetic; Mixed mydriatics; Mydriatics for Horner's syndrome; Adverse effects of mydriatics; References; Chapter 7. Miotics; Ideal properties. | |
| 505 | 8 | |a Indications for useAdvantages; Disadvantages; Mode of action; Parasympathomimetic miotics; Pilocarpine; Carbachol; Acetylcholine chloride + mannitol; Bethanecol chloride; Methacholine chloride; Anticholinesterases; Physostigmine (eserine); Irreversible anticholinesterases; Dyflos (DFP) or di-isopropylfluorophosphonate (Isofluorophate, UPS); Ecothiopate iodide (Ecothiophate iodide USP) (Phospholine Iodide); Alpha-blocking agents; Choice of miotic; Mixed miotics; Miotics for Adie's pupil; Adverse reactions to miotics; References; Chapter 8. Local anaesthetics; Ideal properties. | |
| 505 | 8 | |a Indications for useAdvantages; Disadvantages; Mode of action; Choice of topical anaesthetic; Proxymetacaine hydrochloride (Proparacaine Hydrochloride, USP) (Ophthaine: Alcaine, Canada, USA: Ophthetic, Australia, Canada, South Africa, USA); Oxybuprocaine hydrochloride (benoxinate hydrochloride) (Novesine, Australia, South Africa; Dorsacaine, USA); Lignocaine hydrochloride (Lidocaine Hydrochloride, Eur. P., USP)(Xylocaine); Amethocaine hydrochloride (Tetracaine Hydrochloride Eur. P., USP) {Anethaine, Decicain, Australia: Pontocaine, Canada, USA); Adverse reactions to local anaesthetics. | |
| 520 | |a The Actions and Uses of Ophthalmic Drugs, Third Edition discuses the application and discrimination in the use of ophthalmic drugs. The book reviews the general pharmacological principles including drug nomenclature, pharmacological classification, pharmacokinetics, pharmacodynamics, and the use of these drugs. Ophthalmic drugs (cycloplegics, mydriatics, miotics) directly or indirectly, stimulate or inhibit a part of the autonomic nervous system connected to the intra-ocular muscles. The text investigates in detail the structure and function of this involuntary nervous system in the orbital re. | ||
| 650 | 0 | |a Ophthalmic drugs. | |
| 650 | 2 | |a Eye Diseases |x drug therapy |0 (DNLM)D005128Q000188 | |
| 650 | 2 | |a Ophthalmic Solutions |x pharmacology |0 (DNLM)D009883Q000494 | |
| 650 | 6 | |a M�edicaments ophtalmiques. |0 (CaQQLa)201-0070297 | |
| 650 | 7 | |a MEDICAL |x Surgery |x General. |2 bisacsh | |
| 650 | 7 | |a Ophthalmic drugs |2 fast |0 (OCoLC)fst01046483 | |
| 653 | |a Man |a Eyes |a Effects of drugs | ||
| 700 | 1 | |a Hopkins, G. A. | |
| 700 | 1 | |a Pearson, R. M. |q (Richard M.) | |
| 776 | 0 | 8 | |i Print version: |a Davies, P.H. O'Connor (Patrick Henry O'Connor), 1922- |t Actions and uses of ophthalmic drugs. |b 3rd ed. |d London ; Boston : Butterworths, 1989 |w (DLC) 89015840 |w (OCoLC)19970443 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780407007994 |z Texto completo |